These results also suggested that the loss of hTERT repression by HoxC5 may be an alternative mechanism in activating hTERT expression in human cancers, especially for cancers (such as TGCT and THYM) derived from tissues with high telomerase activity. This evidence concerns the gene HOXC5 and cancer.